Lidocaine Hydrochloride Noridem

Lidocaine Hydrochloride, the active ingredient in Lidocaine Hydrochloride Noridem, is a local anesthetic presented as a sterile solution for epidural, intradermal, and intramuscular use. It provides reversible loss of sensation for minor surgical, diagnostic, and analgesic procedures in adult patients.

GNH USA supplies Lidocaine Hydrochloride Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics and procurement teams worldwide, ensuring quality, regulatory compliance and reliable logistics for global distribution. The company adheres to EU GMP standards and provides full documentation for import and customs clearance.

Lidocaine Hydrochloride is used to provide local anesthesia in various clinical settings where nerve impulse transmission must be temporarily blocked.

- Minor surgical procedures: provides localized numbness to facilitate incision and suturing. - Epidural analgesia: produces segmental loss of sensation for pain control during labor or surgery. - Intradermal diagnostic procedures: creates temporary skin anesthesia for biopsies or allergy testing. - Intramuscular anesthesia: enables painless muscle injections for therapeutic or diagnostic purposes.

Adverse reactions may occur following administration of lidocaine.

Common Side Effects: - Transient burning or stinging at the injection site. - Mild dizziness or light‑headedness. - Nausea or mild gastrointestinal discomfort. - Tinnitus (ringing in the ears). - Localized swelling or erythema.

Serious or Rare Side Effects: - Systemic toxicity presenting as central nervous system depression, seizures, or coma. - Cardiac arrhythmias, including ventricular tachycardia or heart block. - Severe allergic reactions such as anaphylaxis. - Methemoglobinemia (rare blood disorder). - Persistent neurologic deficits in case of high systemic exposure.

When using Lidocaine Hydrochloride, clinicians should observe specific safety measures.

- Assess patient allergy: confirm no known hypersensitivity to amide‑type local anesthetics. - Use lowest effective dose: limit total administered amount to reduce toxicity risk. - Monitor cardiac function: observe ECG, especially in patients with pre‑existing heart disease. - Avoid in severe hepatic impairment: adjust dosing or consider alternative agents. - Consider pregnancy status: weigh potential benefits against unknown fetal risk. - Store below 25°C: keep in the original container, protect from moisture.

Lidocaine Hydrochloride can interact with several medications, requiring careful management.

Major Interactions (Avoid): - Class I antiarrhythmic drugs (e.g., quinidine, procainamide): may increase plasma lidocaine levels. - Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): can raise systemic exposure. - Amiodarone: synergistic cardiac effects may lead to arrhythmias.

Moderate Interactions (Monitor Closely): - Beta‑blockers (e.g., propranolol): may enhance central nervous system depression. - Concurrent use of other local anesthetics: risk of cumulative toxicity. - Diuretics (e.g., furosemide): may alter plasma protein binding and affect lidocaine concentration.